Canada Gazette, Part I, Volume 153, Number 14: GOVERNMENT NOTICES

April 6, 2019

DEPARTMENT OF THE ENVIRONMENT
DEPARTMENT OF HEALTH

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Publication after screening assessment of eight substances of the Phenol-formaldehyde Resins Group specified on the Domestic Substances List (subsection 77(1) of the Canadian Environmental Protection Act, 1999)

Whereas the eight substances identified in the annex below are substances identified under subsection 73(1) of the Canadian Environmental Protection Act, 1999;

Whereas a summary of the draft screening assessment conducted on these substances pursuant to section 74 of the Act is annexed hereby;

And whereas it is proposed to conclude that the substances do not meet any of the criteria set out in section 64 of the Act,

Notice therefore is hereby given that the Minister of the Environment and the Minister of Health (the ministers) propose to take no further action on these substances at this time under section 77 of the Act.

Public comment period

As specified under subsection 77(5) of the Canadian Environmental Protection Act, 1999, any person may, within 60 days after publication of this notice, file with the Minister of the Environment written comments on the measure the ministers propose to take and on the scientific considerations on the basis of which the measure is proposed. More information regarding the scientific considerations may be obtained from the Canada.ca (Chemical Substances) website. All comments must cite the Canada Gazette, Part I, and the date of publication of this notice and be sent to the Executive Director, Program Development and Engagement Division, Department of the Environment, Gatineau, Quebec K1A 0H3, by fax to 819‑938‑5212, or by email to eccc.substances.eccc@canada.ca. Comments can also be submitted to the Minister of the Environment using the online reporting system available through Environment and Climate Change Canada’s Single Window.

In accordance with section 313 of the Canadian Environmental Protection Act, 1999, any person who provides information in response to this notice may submit with the information a request that it be treated as confidential.

Jacqueline Gonçalves
Director General
Science and Risk Assessment Directorate
On behalf of the Minister of the Environment

David Morin
Director General
Safe Environments Directorate
On behalf of the Minister of Health

ANNEX

Summary of the draft screening assessment of the Phenol-formaldehyde Resins Group

Pursuant to section 74 of the Canadian Environmental Protection Act, 1999 (CEPA), the Minister of Environment and the Minister of Health have conducted a screening assessment of eight substances referred to collectively as the Phenol-formaldehyde Resins Group. Substances in this group were identified as priorities for assessment as they met the categorization criteria under subsection 73(1) of CEPA. The Chemical Abstracts Service Registry Numbers (CAS RNs), the Domestic Substances List (DSL) names and the abbreviations of these substances are listed in the table below.

Substances in the Phenol-formaldehyde Resins Group
CAS RNtable 1 note a DSL name Abbreviation
9003-35-4 Phenol, polymer with formaldehyde PFR
25085-50-1 Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol t-BPF
26022-00-4 Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol, 4,4’-(1-methylethylidene)bis[phenol] and 4-methylphenol pC-BPA-tBPF
32610-77-8 Formaldehyde, polymer with N,N’-bis(2-aminoethyl)-1,2-ethanediamine and phenol TETA-PF
54579-44-1 Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol and 4,4’-(1-methylethylidene)bis[phenol] BPA-tBPF
55185-45-0 Formaldehyde, polymer with ammonia, 2-methylphenol and phenol oC-A-PF
67700-42-9 Cashew, nutshell liq., polymer with formaldehyde and phenol CNSL-PF
71832-81-0 Benzenesulfonic acid, hydroxy-, monosodium salt, polymer with formaldehyde and 4,4’-sulfonylbis[phenol] NaPS-BPSF

Table 1 Note

Table 1 Note a

The Chemical Abstracts Service Registry Number (CAS RN) is the property of the American Chemical Society, and any use or redistribution, except as required in supporting regulatory requirements and/or for reports to the Government of Canada when the information and the reports are required by law or administrative policy, is not permitted without the prior, written permission of the American Chemical Society.

Return to table 1 note a referrer

These eight substances were previously evaluated under the Second Phase of Polymer Rapid Screening, which identified phenol-formaldehyde resins as having low potential to cause ecological harm. However, these substances were identified as requiring further assessment due to their potential human health risk on the basis of structural alerts and/or uses associated with significant consumer exposure. The present assessment summarizes the approach applied during the Second Phase of Polymer Rapid Screening and further elaborates on the potential for phenol-formaldehyde resins to cause harm to human health in order to reach an overall conclusion under section 64 of CEPA as to whether they pose a risk to the environment or human health.

Phenol-formaldehyde resins do not occur naturally in the environment but are prepared industrially. They do not contain any reactive functional group (RFG) associated with adverse human health effects. In addition, most phenol-formaldehyde resins in commercial and consumer applications are present in cured form. In Canada, phenol-formaldehyde resins are reported to be used as adhesives, sealants, process aids, intermediates, corrosion inhibitors, fillers, bleaching agents, encapsulating agents, surface active agents, fixing agents (dying auxiliary), and abrasives. They are used in several industries, such as plastics and rubbers, paints/inks, food packaging (including cans), coatings, building/construction, printed circuit boards, electronics, oil and gas, metal, auto care, fabrics, textile, leather, cosmetics, and toys (as thermoset plastic).

No information regarding the manufactured amount of phenol-formaldehyde resins in Canada has been reported. However, it has been reported that volumes as low as 100 kg (for NaPS-BPSF) and in the range up to 10 000 000 kg (for PFR) were imported into Canada in 2014.

Ecological screening of the eight phenol-formaldehyde resins was performed in the Second Phase of Polymer Rapid Screening (ECCC, HC 2018). These eight resins were identified as either substances with low import and manufacturing quantities or low water solubility/extractability, or were otherwise determined to pose a low ecological risk.

Considering all available lines of evidence presented in this assessment, there is a low risk of harm to the environment from phenol-formaldehyde resins. It is proposed to conclude that these substances do not meet the criteria under paragraph 64(a) or (b) of CEPA as they are not entering the environment in a quantity or concentration or under conditions that have or may have an immediate or long-term harmful effect on the environment or their biological diversity or that constitute or may constitute a danger to the environment on which life depends.

Both direct exposure (oral, inhalation, dermal) and indirect exposure (through drinking water) of the general population to phenol-formaldehyde resins are not expected or are thought to be minimal. Therefore, these substances likely present a low risk or no risk of harm to human health.

In addition, on the basis of further evaluation, one of the phenol-formaldehyde resins (pC-BPA-tBPF, CAS RN 26022-00-4) was identified as a substance which could meet the same criteria that are used to designate a substance as being of low concern under the New Substances Notification Regulations (Chemicals and Polymers) of CEPA, in particular, the reduced regulatory requirement (RRR) polymers criterion in paragraph 9(b) of those Regulations. Polymers that are described by this criterion have a limited percentage of low-molecular-weight components, are chemically stable and do not contain reactive components; therefore, they present low human health concern. This substance is therefore unlikely to be a concern to human health.

On the basis of the information presented in this screening assessment, it is proposed to conclude that phenol-formaldehyde resins do not meet the criteria under paragraph 64(c) of CEPA as they are not entering the environment in a quantity or concentration or under conditions that constitute or may constitute a danger to human life or health in Canada.

Proposed conclusion

It is proposed to conclude that the eight substances do not meet any of the criteria set out in section 64 of CEPA.

The draft screening assessment for this substance is available on the Canada.ca (Chemical Substances) website.

DEPARTMENT OF THE ENVIRONMENT
DEPARTMENT OF HEALTH

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Publication after screening assessment of eight substances of the Used and Re-refined Oils Group specified on the Domestic Substances List (subsection 77(1) of the Canadian Environmental Protection Act, 1999)

Whereas the eight substances identified in the annex below are substances identified under subsection 73(1) of the Canadian Environmental Protection Act, 1999;

Whereas a summary of the draft screening assessment conducted on these substances pursuant to section 74 of the Act is annexed hereby;

And whereas it is proposed to conclude that the substances do not meet any of the criteria set out in section 64 of the Act,

Notice therefore is hereby given that the Minister of the Environment and the Minister of Health (the ministers) propose to take no further action on these substances at this time.

Public comment period

As specified under subsection 77(5) of the Canadian Environmental Protection Act, 1999, any person may, within 60 days after publication of this notice, file with the Minister of the Environment written comments on the measure the ministers propose to take and on the scientific considerations on the basis of which the measure is proposed. More information regarding the scientific considerations may be obtained from the Canada.ca (Chemical Substances) website. All comments must cite the Canada Gazette, Part I, and the date of publication of this notice and be sent to the Executive Director, Program Development and Engagement Division, Department of the Environment, Gatineau, Quebec K1A 0H3, by fax to 819‑938‑5212, or by email to eccc.substances.eccc@canada.ca. Comments can also be submitted to the Minister of the Environment using the online reporting system available through Environment and Climate Change Canada’s Single Window.

In accordance with section 313 of the Canadian Environmental Protection Act, 1999, any person who provides information in response to this notice may submit with the information a request that it be treated as confidential.

Jacqueline Gonçalves
Director General
Science and Risk Assessment Directorate
On behalf of the Minister of the Environment

David Morin
Director General
Safe Environments Directorate
On behalf of the Minister of Health

ANNEX

Summary of the draft screening assessment of the Used and Re-refined Oils Group

Pursuant to section 74 of the Canadian Environmental Protection Act, 1999 (CEPA), the Minister of the Environment and the Minister of Health have conducted a screening assessment of eight of nine substances referred to collectively as the Used and Re-refined Oils Group. Substances in this group were identified as priorities for assessment, as they met the categorization criteria under subsection 73(1) of CEPA. The Chemical Abstracts Service Registry Numbers (CAS RNs), footnote 1 the Domestic Substances List (DSL) names, and the simplified names of these substances are listed in the table below.

Lubricant oils, used (CAS RN 70514-12-4), henceforth referred to as used oil, was found to meet the broad classification of used crankcase oils, and is considered to have been addressed through the Priority Substances List Assessment Report of Waste/Used Crankcase Oil in 1994, and the follow-up report in 2005. This substance will therefore not be subject to further risk assessment work at this time under the Chemicals Management Plan (CMP), given previous regulatory activities.

Substances in the Used and Re-refined Oils Group
CAS RNtable 2 note a DSL name Simplified name
70514-12-4 Lubricant oils, used Used oil
129893-17-0 Lubricant oils, used, residues Used oil residue
92045-41-5 Lubricant oils, used, vacuum distd. Used vacuum gas oil
129566-94-5 Hydrocarbons, C12-25, dehydrated used lubricating oil distillates C12-25 used distillate
132538-91-1 Lubricant oils, used, distd., C5-18 fraction C5-18 used distillate
132538-93-3 Lubricant oils, used, distd., light oil Used light oil
125471-97-8 Lubricating oils (petroleum), hydrotreated, used, distd., residues Hydrotreated used residue
68476-77-7 Lubricating oils, refined used Refined used oil
129893-18-1 Lubricating oils, used, vacuum distd., clay-treated Clay-treated used oil

Table 2 Note

Table 2 Note a

All CAS RNs are UVCB substances (substances of unknown or variable composition, complex reaction products, or biological material).

Return to table 2 note a referrer

The Used and Re-refined Oils Group includes used oil and substances produced during the re-processing and re-refining process. Used oil refers to all used lubricant oils that are collected, transported, and stored. Used oil residue applies to a non-volatile residual stream generated as a by-product of re-refining and re-processing operations. Refined used oil and clay-treated used oil are base oils with commercial and industrial applications, and the end product of the re-refining process. The remaining substances are intermediate lubricant oils generated as by-products during the re-refining and/or re-processing operations and have various industrial applications.

Used oil residue, used vacuum gas oil, C12-25 used distillate, C5-18 used distillate, used light oil, hydrotreated used residue, refined used oil and clay-treated used oil have similar physical and chemical properties and uses to the used crankcase oils, asphalts, base oils, and other substances that have been previously assessed under CEPA. Exposures from these uses were characterized in those assessments. No environmental and general population exposures of these eight substances, beyond those that were previously assessed, are expected.

Considering all available lines of evidence presented in this draft screening assessment, there is a low risk of harm to the environment from used oil residue, used vacuum gas oil, C12-25 used distillate, C5-18 used distillate, used light oil, hydrotreated used residue, refined used oil and clay-treated used oil. It is proposed to conclude that used oil residue, used vacuum gas oil, C12-25 used distillate, C5-18 used distillate, used light oil, hydrotreated used residue, refined used oil and clay-treated used oil do not meet the criteria under paragraph 64(a) or (b) of CEPA, as they are not entering the environment in a quantity or concentration or under conditions that have or may have an immediate or long-term harmful effect on the environment or its biological diversity or that constitute or may constitute a danger to the environment on which life depends.

On the basis of the information presented in this draft screening assessment, exposures to used oil residue, used vacuum gas oil, C12-25 used distillate, C5-18 used distillate, used light oil, hydrotreated used residue, refined used oil and clay-treated used oil for the general population are not expected. These substances are used as industrial intermediates and do not appear in products available to consumers. It is proposed to conclude that used oil residue, used vacuum gas oil, C12-25 used distillate, C5-18 used distillate, used light oil, hydrotreated used residue, refined used oil and clay-treated used oil do not meet the criteria under paragraph 64(c) of CEPA, as they are not entering the environment in a quantity or concentration or under conditions that constitute or may constitute a danger in Canada to human life or health.

Proposed conclusion

It is proposed to conclude that the eight substances in the Used and Re-refined Oils Group do not meet any of the criteria set out in section 64 of CEPA.

The draft screening assessment for these substances is available on the Canada.ca (Chemical Substances) website.

DEPARTMENT OF HEALTH

CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999

Notice with respect to the Proposed Code of Practice for Certain Methylenediphenyl Diisocyanates in Low-Pressure Two-Component Spray Polyurethane Foam Products

Whereas a screening assessment of benzene, 1,1′-methylenebis[4-isocyanato-; benzene, 1,1′-methylenebis[2-isocyanato-; benzene, 1-isocyanato-2-[(4-isocyanatophenyl)methyl]-; benzene, 1,1′-methylenebis[isocyanato-; and isocyanic acid, polymethylenepolyphenylene ester conducted under section 74 of the Canadian Environmental Protection Act, 1999 has concluded that the substances meet one or more of the criteria set out in section 64 of the Canadian Environmental Protection Act, 1999;

Whereas on April 6, 2019, the Minister of the Environment and the Minister of Health (the ministers) published in the Canada Gazette, Part I, a statement under subsection 77(6) of the Act indicating their intention to recommend that benzene, 1,1′-methylenebis[4-isocyanato-; benzene, 1,1′-methylenebis[2-isocyanato-; benzene, 1-isocyanato-2-[(4-isocyanatophenyl)methyl]-; benzene, 1,1′-methylenebis[isocyanato-; and isocyanic acid, polymethylenepolyphenylene ester be added to the List of Toxic Substances in Schedule 1 of the Canadian Environmental Protection Act, 1999;

And whereas subsection 91(1) of the Canadian Environmental Protection Act, 1999 requires a regulation or instrument respecting preventive or control action for this substance be proposed and published;

Pursuant to subsection 55(3) of the Canadian Environmental Protection Act, 1999, notice is hereby given that the Minister of Health is issuing the following proposed Code of Practice under subsection 55(1) of that Act:

Proposed Code of Practice for Certain Methylenediphenyl Diisocyanates in Low-Pressure Two-Component Spray Polyurethane Foam Products

Electronic copies of this proposed Code of Practice may be downloaded from the Consulting Canadians (Canada.ca) web page.

Any person may, within 60 days after publication of this notice, file with the Minister of the Environment written comments on the measure the ministers propose to take and on the scientific considerations on the basis of which the measure is proposed. More information regarding the scientific considerations may be obtained from the Canada.ca (Chemical Substances) website. All comments must cite the Canada Gazette, Part I, and the date of publication of this notice and be sent to the Executive Director, Program Development and Engagement Division, Department of the Environment, Gatineau, Quebec K1A 0H3, by fax to 819‑938‑5212, or by email to ec.substances.ec@canada.ca. Comments can also be submitted to the Minister of the Environment using the online reporting system available through Environment and Climate Change Canada’s Single Window.

In accordance with section 313 of the Canadian Environmental Protection Act, 1999, any person who provides information in response to this notice may submit with the information a request that it be treated as confidential.

Gwen Goodier
Acting Director General
Science and Risk Assessment Directorate
On behalf of the Minister of the Environment

David Morin
Director General
Safe Environments Directorate
On behalf of the Minister of Health

Proposed Code of Practice for Certain Methylenediphenyl Diisocyanates in Low-Pressure Two-Component Spray Polyurethane Foam Products

1.0 Glossary

2.0 Objective of the Code of Practice

The objective of this Code of Practice (herein referred to as the “Code”) is to minimize the potential for respiratory sensitization of the general population from exposure to certain methylenediphenyl diisocyanates (MDIs). The Code will help to achieve this objective by promoting consistent health and safety practices and facilitating access to this information in order to help reduce exposure of the general population to MDIs resulting from the use of low-pressure two-component spray polyurethane foam (SPF) products containing MDIs that are available to users. The Code pertains to the MDIs identified in the Substance Groupings Initiative of the second phase of the Chemicals Management Plan (see Table 1).

Table 1: MDIs in the Substance Groupings Initiative
Substance Name Abbreviation CAS RNtable 3 note a
Benzene, 1,1′-methylenebis[4-isocyanato- 4,4′-MDI 101-68-8
Benzene, 1,1′methylenebis[2-isocyanato 2,2′-MDI 2536-05-2
Benzene, 1-isocyanato-2-[(4-isocyanatophenyl)methyl]- 2,4′-MDI 5873-54-1
Isocyanic acid, polymethylenepolyphenylene ester pMDI 9016-87-9
Benzene, 1,1′-methylenebis[isocyanato- Mixed MDI 26447-40-5

Table 3 Note

Table 3 Note a

CAS RN: Chemical Abstracts Service Registry Number. The Chemical Abstracts Service Registry Number is the property of the American Chemical Society, and any use or redistribution, except as required in supporting regulatory requirements and/or for reports to the Government of Canada when the information and the reports are required by law or administrative policy, is not permitted without the prior, written permission of the American Chemical Society.

Return to table 3 note a referrer

All applicable municipal, provincial, territorial, and federal laws pertaining to these substances must still be met, and a commitment by any person to adopt the Code does not remove obligations to comply with those requirements.

3.0 Background and scope

3.1 The five MDIs are part of the Methylenediphenyl Diisocyanate and Diamine (MDI and MDA) Substance Grouping that was assessed under phase two of the Government of Canada’s Chemicals Management Plan. The final screening assessment for MDIs concluded that all five substances are entering or may enter the environment in a quantity or concentration or under conditions that constitute or may constitute a danger in Canada to human life or health and therefore meet the criteria set out in paragraph 64(c) of the Canadian Environmental Protection Act, 1999. The conclusion is based on concerns for dermal and inhalation exposure to MDIs during application of low-pressure two-component SPF products.

3.2 MDIs are widely used in the production of a wide range of products, including polyurethanes, adhesives, sealants, paints and coatings. These products are used across a variety of sectors, including construction, transportation, machinery, packaging, and furniture.

MDIs are isocyanates used to manufacture SPF systems, including low-pressure two-component products. The MDIs in these products, commonly referred to as the “A Side,” are combined with polyol chemical components, commonly referred to as the “B Side,” to create polyurethane foam. When the product is applied, the A Side and B Side components react quickly to form polyurethane foam.

3.3 Low-pressure two-component SPF products meet National Building Code of Canada 2015 standards, and related material and installation standards, for use only as “air sealants” (i.e. to fill cracks and holes).

3.4 Industry reviews research results related to potential exposures, hazards, and risks to the chemical components of low-pressure two-component SPF products and updates health and safety protocols as needed.

3.5 This Code sets out elements of best practices and recommendations that can help reduce exposure of the general population to MDIs in low-pressure two-component SPF products while maintaining flexibility for effective and efficient implementation.

This Code outlines the following actions to

4.0 Persons to whom the Code applies

4.1 This Code may be adopted by any person who

5.0 Products to which the Code applies

5.1 This Code is applicable to low-pressure two-component SPF products containing MDIs available to users.

6.0 Products excluded from the Code

6.1 This Code does not apply to products used for commercial purposes, including

6.2 This Code does not apply to low-pressure one-component SPF products containing MDIs.

7.0 Elements of the Code

7.1 Potential exposure of users to low-pressure two-component SPF products containing MDIs may be mitigated by

7.2 Information on safe use and handling may include, but is not limited to, the following:

7.3 Promoting access to information on safe use and handling may include, but is not limited to, the following:

8.0 Recommended packaging, labelling, and documentation on safe use and handling

8.1 A person who adopts this Code must comply with the Consumer Chemicals and Containers Regulations, 2001.

8.2 Additional packaging and labelling may include, but is not limited to, language to

8.3 A person who adopts this Code should provide documentation to the user which includes, but is not limited to

9.0 Recommended implementation practices

9.1 A person who adopts this Code should make available to users training materials and other information on responsible health and safety practices to promote safe use and handling of low-pressure two-component SPF products.

9.2 For manufacturers and/or importers, training materials and other information may include, but are not limited to, one or more of the following:

9.3 A person who adopts this Code should establish practices to facilitate access for users to training materials and other information to promote safe use and handling of low-pressure two-component SPF products and to information on responsible health and safety practices.

9.4 For retailers, mechanisms to facilitate access to training materials and other information may include, but are not limited to, one or more of the following:

10.0 Record keeping and reporting

10.1 Any person who adopts this Code should provide written notice to Health Canada upon adoption of sections 7.0, 8.0, and 9.0 of the Code. This notice will detail the specific low-pressure two-component SPF products to which this Code applies as outlined in section 5.0. A Declaration Form has been provided in Appendix 1 of the Code.

10.2 Any person who adopts this Code should keep electronic or paper records of the information below for a period of at least five years after the day on which the records were completed in order to satisfy reporting requirements as outlined in sections 10.3 and 10.4:

10.3 Any person who adopts this Code should send a report to Health Canada by March 31 of the calendar year following the final publication of the Code in order to establish baseline data. The report should cover the previous calendar year’s activities. Subsequent reports should be sent every two years by March 31 of those years and should cover activities relevant to the previous calendar year. The report should include the product name, the MDI contained in the product, and information regarding the implementation of the Code. Reporting questions are provided in Appendix 2 of the Code. This information will be used to evaluate whether the objective of the Code was achieved.

10.4 Notice should be provided to Health Canada when products and/or practices related to the safe use and handling of products has changed, or if a person who has adopted the Code permanently ceases to manufacture, import, or sell to users low-pressure two-component SPF products containing MDIs.

11.0 Confidentiality

11.1 In this section, “confidential business information,” with respect to a person to whose business or affairs the information relates, means business information

11.2 Requests for confidentiality

A person who provides information to the Minister of Health under this Code must submit a written request identifying the specific information to be treated as confidential business information as well as a rationale for the request. If the Minister considers that the information does not meet the definition of confidential business information, a written notice will be given to this effect to the person who had provided the information to the Minister.

The Minister of Health will use and disclose confidential business information in respect of which a request for confidentiality has been made as permitted by law. For greater certainty, personal information as defined in section 3 of the Privacy Act will be used and disclosed in accordance with that Act.

12.0 Contact information to submit declarations and reports

12.1 Declarations and reports should be submitted to Health Canada by mail, email, or fax to the following addresses. Please type “Declaration for Code of Practice for MDI Substances” or “Report on Implementation of the Code of Practice for MDI Substances,” as appropriate, in the subject line of the message.

Email:
HC.chemicalsubstances-chimiques.SC@canada.ca
Mail:
Canada.ca (Chemical Substances) website
c/o Health Canada
269 Laurier Avenue West
Address Locator 4905B
Ottawa, Ontario
K1A 0K9

13.0 Review of progress and need for further action

13.1 Within five years after publication of this Code in the Canada Gazette, Part I, the Minister of Health may initiate a review of the adoption of the Code and the progress the Code has achieved towards helping to reduce exposure of the general population to MDIs in low-pressure two-component SPF products that are available to users.

13.2 The review will inform if other steps or programs are needed to further help minimize exposure of the general population to MDIs in low-pressure two-component SPF products that are available to users.

13.3 A periodic review of the adoption of the Code may be undertaken if it is deemed necessary after the initial review is completed.

Appendix 1: Declaration Form

This form may be used as a template to provide information to Health Canada in respect of Section 10 of the Code of Practice.

1. Contact information

2. Declaration

I declare that [insert Company name] has adopted the Code of Practice for Certain Methylenediphenyl Diisocyanates in Low-Pressure Two-Component Spray Polyurethane Foam Products.


Submitter Name (print)


Telephone Number


Submitter Signature


Submitter Title


Email Address


Date of Signature

Request for Confidentiality

Confidentiality will be considered as under Section 11 of the Code of Practice. Please identify specific sections that are requested to be treated as confidential.

Appendix 2: Proposed Code of Practice for Certain Methylenediphenyl Diisocyanates in Low-Pressure Two-Component Spray Polyurethane Foam Products — Reporting Information

Section 1: Company information

1.1 Company information

Name of organization  
Civic address  
Telephone number  
Email  
Fax number (if applicable)  
Technical contact  
Title  
Telephone number  
Email  
Signature  
Date  

1.2 Identify the activity of the company with the products subject to this Code of Practice. Indicate all that apply.

Manufacture Indicate "yes", "no", or "not applicable"
Import Indicate "yes", "no", or "not applicable"
Retail Indicate "yes", "no", or "not applicable"

Section 2: Reporting year

Reporting year XXXX
Is this the first time reporting? Indicate "yes" or "no"
If no, identify all previous years of reporting List of years

Section 3: Product information

3.1 For each product containing a MDI that is subject to this Code, provide the following information:

(a) Full product name (b) CAS RN of MDI substances contained in product (c) Activity with the products (manufacture, import, retail)
     
     

Section 4: Packaging, labelling and documentation on safe use and handling

4.1 For each product manufactured or imported, and identified in Section 3, provide the following information on packaging and labelling:

(a) Full product name (b) Whether packaging and labelling indicate the intended uses and limitations (Indicate "yes" or "no") (c) Whether packaging and labelling provides safe use and handling information, including instructions and how to locate information (Indicate "yes" or "no") (d) Whether safety information is provided on the outer packaging (Indicate "yes" or "no") (e) Whether the outer packaging and labelling identify recommended types of PPE with an image and description (Indicate "yes" or "no") (f) Additional notes

4.2 For each product manufactured or imported, and identified in Section 3, provide the following information on documentation:

(a) Full product name (b) Whether manufacture-recommended applications for product use are identified (Indicate "yes" or "no") (c) Whether instructions for proper use and application are provided (Indicate "yes" or "no") (d) Whether documentation on recommended types of PPE is provided (Indicate "yes" or "no") (e) Whether information on ventilation and application site preparation techniques is provided (Indicate "yes" or "no")
(f) Whether instructions for storage, clean up and disposal are provided (Indicate "yes" or "no") (g) Whether re-occupancy instructions for non-users are provided (Indicate "yes" or "no") (h) Whether contact information for user support and questions is provided (Indicate "yes" or "no") (i) Additional notes

Section 5: Implementation practices

5.1 For manufacturers and importers, provide the following information on training materials and other information to promote safe use and handling:

(a) Whether training materials are included with the product (Indicate "yes" or "no" (b) List the types of training materials (c) Whether online or electronic technical or safety materials are available to users (Indicate "yes" or "no" (d) Identify the platform of access to online or electronic materials (such as, but not limited to QR codes, published websites, training from the manufacturer, industry-supported resources, other) (e) Total number of hits per year for each platform (f) Demographic information for those accessing each platform, if available (general population, professional, other [identify])
(g) Are in-person training sessions offered to retailers (Indicate "yes" or "no") (h) Total number of training sessions given per year (i) Total number of attendees per year, if available (j) Whether technical staff are available for user support and questions (Indicate "yes" or "no") (k) Whether Safety Data Sheets are available (Indicate "yes" or "no") (l) Additional notes

5.2 For retailers, provide the following information on mechanisms to facilitate access to training materials and other safe use and handling resource materials:

(a) Whether media is used to facilitate access within the store (Indicate "yes" or "no") (b) Identify each type of media used (e.g. signage, images of recommended types of PPE, video, pamphlets) (c) If the response to (a) is "no," explain (d) Whether safe use and handling information is provided where the product is located in the retail location (Indicate "yes" or "no" (e) If the response to (d) is "no," explain (f) Whether shelf space for products is close to recommended types of PPE (Indicate "yes" or "no") (g) If the response to (f) is "no," explain
(h) Whether health and safety resources and training programs are promoted to users (Indicate "yes" or "no") (i) If the response to (h) is "yes," explain how (j) If the response to (h) is "no," explain (k) Additional notes

Section 6: Confidentiality

A person who provides information to the Minister of Health under this Code may submit a written request that the information or part of it be treated as confidential business information as well as a rationale for the request. If the Minister considers that the information does not meet the definition of confidential business information, a written notice will be given to this effect to the person who had provided the information to the Minister.

Section 7: Contact information to submit reports

Submit a completed form by March 31 of the calendar year following the final publication of the Code by mail, email, or fax to the following addresses. Please type “Declaration for Code of Practice for MDI Substances” or “Report on Implementation of the Code of Practice for MDI Substances,” as appropriate, in the subject line of the message.

Email:
HC.chemicalsubstances-chimiques.SC@canada.ca
Mail:
Canada.ca (Chemical Substances) website
c/o Health Canada
269 Laurier Avenue West
Address Locator 4905B
Ottawa, Ontario
K1A 0K9

DEPARTMENT OF PUBLIC SAFETY AND EMERGENCY PREPAREDNESS

CRIMINAL CODE

Designation as fingerprint examiner

Pursuant to subsection 667(5) of the Criminal Code, I hereby designate the following persons of the Winnipeg Police Service as fingerprint examiners:

Ottawa, March 25, 2019

Ellen Burack
Assistant Deputy Minister
Community Safety and Countering Crime Branch

PRIVY COUNCIL OFFICE

Appointment opportunities

We know that our country is stronger — and our government more effective — when decision-makers reflect Canada’s diversity. The Government of Canada has implemented an appointment process that is transparent and merit-based, strives for gender parity, and ensures that Indigenous peoples and minority groups are properly represented in positions of leadership. We continue to search for Canadians who reflect the values that we all embrace: inclusion, honesty, fiscal prudence, and generosity of spirit. Together, we will build a government as diverse as Canada.

We are equally committed to providing a healthy workplace that supports one’s dignity, self-esteem and the ability to work to one’s full potential. With this in mind, all appointees will be expected to take steps to promote and maintain a healthy, respectful and harassment-free work environment.

The Government of Canada is currently seeking applications from diverse and talented Canadians from across the country who are interested in the following positions.

Current opportunities

The following opportunities for appointments to Governor in Council positions are currently open for applications. Every opportunity is open for a minimum of two weeks from the date of posting on the Governor in Council Appointments website.

Position Organization Closing date
Chief Administrator Administrative Tribunals Support Service of Canada  
Chairperson Asia-Pacific Foundation of Canada  
Chairperson Canada Development Investment Corporation  
Chairperson Canada Foundation for Sustainable Development Technology  
Chairperson and Vice-Chairperson Canada Industrial Relations Board  
Chairperson Canada Lands Company Limited  
President and Chief Executive Officer Canada Lands Company Limited  
Chairperson (joint federal Governor in Council and provincial Lieutenant Governor appointment) Canada–Newfoundland and Labrador Offshore Petroleum Board  
Chairperson Canada Science and Technology Museum  
Vice-Chairperson Canada Science and Technology Museum  
Board Member (Anticipatory) Canadian Accessibility Standards Development Organization  
Chairperson (Anticipatory) Canadian Accessibility Standards Development Organization  
Chief Executive Officer (Anticipatory) Canadian Accessibility Standards Development Organization  
Vice-Chairperson (Anticipatory) Canadian Accessibility Standards Development Organization  
President and Chief Executive Officer Canadian Commercial Corporation  
Chairperson Canadian Dairy Commission  
Chairperson, Vice-Chairperson and Director Canadian Energy Regulator  
Chief Executive Officer (Anticipatory) Canadian Energy Regulator  
Lead Commissioner, Deputy Lead Commissioner and Commissioner Canadian Energy Regulator  
Pay Equity Commissioner Canadian Human Rights Commission  
Chairperson Canadian Institutes of Health Research  
Vice-Chairperson Canadian Museum of Nature  
Permanent Member Canadian Nuclear Safety Commission  
Regional Member (Quebec) Canadian Radio-television and Telecommunications Commission  
Chairperson and Member Canadian Statistics Advisory Council  
President (Chief Executive Officer) Canadian Tourism Commission  
President and Chief Executive Officer Defense Construction (1951) Limited  
Chairperson Farm Credit Canada  
President and Chief Executive Officer Farm Credit Canada  
Vice-Chairperson Farm Products Council of Canada  
Chairperson The Federal Bridge Corporation Limited  
Commissioner Financial Consumer Agency of Canada  
Chairperson First Nations Financial Management Board  
Chief Commissioner First Nations Tax Commission  
Deputy Chief Commissioner First Nations Tax Commission  
Director Freshwater Fish Marketing Corporation  
Director (Federal) Hamilton Port Authority  
Sergeant-at-Arms and Corporate Security Officer House of Commons  
Member International Authority  
Commissioner and Chairperson International Joint Commission  
Member (appointment to roster) International Trade and International Investment Dispute Settlement Bodies  
Vice-Chairperson Invest in Canada Hub  
Chief Executive Officer The Jacques Cartier and Champlain Bridges Incorporated  
Librarian and Archivist of Canada Library and Archives of Canada  
President and Chief Executive Officer Marine Atlantic Inc.  
Vice-Chairperson National Arts Centre Corporation  
Member National Capital Commission  
Government Film Commissioner National Film Board  
Chairperson National Research Council of Canada  
President Natural Sciences and Engineering Research Council of Canada  
Canadian Ombudsperson Office of the Canadian Ombudsperson for Responsible Enterprise  
Chief Accessibility Officer (Anticipatory) Office of the Chief Accessibility Officer  
Ombudsperson Office of the Ombudsperson for National Defence and Canadian Forces  
Director (Federal) Oshawa Port Authority  
Chairperson Pacific Pilotage Authority  
Chief Executive Officer Parks Canada  
Vice-Chairperson and Member Patented Medicine Prices Review Board  
Member Payment in Lieu of Taxes Dispute Advisory Panel  
Commissioner Public Service Commission  
Member and Alternate Member Renewable Resources Board (Gwich’in)  
Member and Alternate Member Renewable Resources Board (Sahtu)  
Chairperson and Vice-Chairperson Royal Canadian Mounted Police External Review Committee  
Principal Royal Military College of Canada  
Vice-Chairperson
(all streams)
Social Security Tribunal of Canada  
Chairperson Telefilm Canada  
Member (Marine and Medical) Transportation Appeal Tribunal of Canada  
President and Chief Executive Officer VIA Rail Canada Inc.